2018 International Congress

October 5-9, 2018. Hong Kong. Abstracts are presented on the 6th, 7th, and 8th.

View by Title View Sessions

View by Date

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

A Randomized Trial of Deferiprone for Pantothenate Kinase-Associated Neurodegeneration

T. Klopstock, F. Tricta, L. Neumayr, I. Karin, G. Zorzi, C. Fradette, T. Kmieć, B. Buechner, H. Steele, R. Horvath, P. Chinnery, A. Basu, C. Küpper, C. Neuhofer, P. Dušek, F. Zhao, F. Zibordi, N. Nardocci, C. Aguilar, S. Hayflick, M. Spino, A. Blamire, P. Hogarth, E. Vichinsky (Munich, Germany)
A randomized, double-blind, placebo-controlled Phase II Efficacy and Safety Study of the PDE10A inhibitor PF-02545920 in Huntington Disease (AMARYLLIS)

M. Delnomdedieu, Y. Tan, A. Ogde, Z. Berger, R. Reilmann (Cambridge, MA, USA)
A Real-world Assessment of Hospitalizations Due to Falls among Patients with and without OFF episodes in Parkinson’s Disease

K. Rajagopalan, A. Lee, J. Barton, J. Pike (Marlborough, MA, USA)
A Registry of Real-World Outcomes Using Deep Brain Stimulation for the Treatment of Dystonia

J. Krauss, C. Nicholson, M. Barbe, V. Visser-Vanderwalle, A. Kuehn, M. Poetter-Nerger, R. Jain, H. Scholtes, N. Van Dyck, A. Albanese (Hannover, Germany)
A review of modifiers of Parkinsonism in the Leucine-rich repeat kinase 2 (LRRK2) population

J. Staisch (Portland, OR, USA)
A single center retrospective analysis of Opicapone treatment in 90 Parkinson patients

M. Winterholler, H. Erxleben (Schwarzenbruck, Germany)
A strategic approach to understand microsatellite repeat loci among Indian spinocerebellar ataxia patients

V. Suroliya, M. Faruq, A. Srivastava (New Delhi, India)
A study of correlation between screening tools for cognitive decline and gait status using three-dimensional gait analysis

PJ. Park (Busan, Republic of Korea)
A Study of Pain in Parkinson’s Disease

S. Meenakshisundaram, B. Samivel, T. Sundaram, LN. Ranganathan (Chennai, India)
A Study on Combined Brain Positron Emission Tomography (PET) – Magnetic Resonance Imaging (MRI) Using Fluorodeoxyglucose (18FDG) (FDG-PET/MRI) in Premanifest Huntington’s Disease Gene-expansion Carriers

M. Hellem, T. Vinther-Jensen, C. Hansen, E. Budtz-Jørgensen, L. Hjermind, I. Law, J. Nielsen (Copenhagen, Denmark)

« Previous Page
1
…
6
7
8
9
10
…
177
Next Page »

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z